An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia
Acerta Pharma BV
Acerta Pharma BV
Gilead Sciences
Acerta Pharma BV
Janssen Research & Development, LLC
Janssen Pharmaceutical K.K.
BeiGene
BeiGene
TG Therapeutics, Inc.
Karyopharm Therapeutics Inc
ADC Therapeutics S.A.
Pharmacyclics LLC.
Eli Lilly and Company
Gilead Sciences
Pharmacyclics LLC.
Acrotech Biopharma Inc.
Idera Pharmaceuticals, Inc.
Gilead Sciences
Takeda
Gilead Sciences
Gilead Sciences
Idera Pharmaceuticals, Inc.
GlaxoSmithKline
Amgen
INSYS Therapeutics Inc